Plain-English translation of NCT06717984 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →This trial is testing a new artificial intelligence (AI) computer program that analyzes breast tissue samples collected during biopsies. The AI is designed to automatically identify whether tissue is normal, benign (harmless), or cancerous — and if cancerous, whether it's early-stage or more advanced. By automating this analysis, researchers hope to make breast cancer diagnosis faster, more consistent, and available to more patients.
Currently, doctors manually examine breast tissue samples under a microscope to diagnose breast cancer, which can be time-consuming, subjective, and varies depending on the doctor's experience. This trial exists to see whether AI can perform this analysis more accurately and efficiently, potentially catching breast cancer earlier and improving outcomes for patients.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would undergo a standard breast biopsy (a procedure where a small tissue sample is collected from your breast). Your tissue sample would then be analyzed using the new AI tool being tested, and the AI's results would be compared with traditional diagnostic methods. The research team would use your sample and medical records to help train and evaluate the AI program, with the goal of improving how it identifies breast cancer.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Bangladesh